Women’s cancers: chemo then surgery does not beat chemoradiation for cervical cancer
Breast, ovarian and uterine cancerPart of a story we are following · 11 articles · See every update
If you or someone you love is facing advanced cervical cancer, here is where things stand: a new review looked at an alternative to the standard treatment and did not find it better. Among women’s cancers, this one has a clear message for now. In a review of 3 clinical trials with 1,326 women who had locally advanced cervical cancer, chemotherapy followed by surgery did not lead to longer survival than chemoradiation, and severe short-term side effects were more common.
That is not the news many people hoped for. The alternative was proposed because chemoradiation can be hard on the body and because radiation equipment is not available everywhere. This review says the alternative is not ready to take its place.
How the study worked
This was a Cochrane review, which pools the results of earlier randomized trials, published in the Cochrane Database of Systematic Reviews on November 20, 2026. The authors searched medical databases up to May 20, 2026, and combined 3 trials that compared the two treatments in women with locally advanced cervical cancer. Because there were only a few trials, some results are very uncertain, and the older radiation methods used in those trials make the late side effects especially hard to judge.
What are the two treatments?
Chemoradiation, often called CRT, combines chemotherapy with radiation. It is the standard treatment for locally advanced cervical cancer.
The alternative gives chemotherapy first, then a major operation to remove the cancer. Doctors call the first step neoadjuvant chemotherapy. The idea was that it could work well where radiation is hard to get.
What they found
Survival after five years. Women who had chemo plus surgery lived about as long as women who had chemoradiation. The review found little to no difference in five-year overall survival. This result came from 2 of the trials, covering 1,259 women.
Cancer coming back or growing. Here the picture is less clear. Only one trial measured how long women stayed free of disease, and only one measured how long before the cancer grew or returned. The review calls both results very uncertain. In the trial that tracked growth or return, women who had chemo plus surgery did somewhat worse.
Short-term side effects. Severe side effects in the weeks after treatment were probably more common with chemo plus surgery. This finding came from 2 trials with 1,224 women, and it is the most solid result in the review.
Long-term side effects. The evidence is very uncertain. Only one trial, with 591 women, reported on them, and the radiation used was older than what many centers use today.
Quality of life. Two years after treatment, quality of life looked about the same in both groups. The average score difference was 0.48 points on the scale used, which is tiny. This came from 2 trials with 239 women.
What does this mean for treatment choices?
The authors conclude that the evidence does not support chemo plus surgery as an alternative to chemoradiation. Chemoradiation remains the standard of care where high-quality radiation is available.
Where good radiation is not available, the review says there is still not enough evidence to recommend chemo plus surgery instead. That leaves an open question, and more high-quality trials would be needed to answer it.
What you can do today
Nothing about current advice changes because of this review. Chemoradiation is still the standard treatment for locally advanced cervical cancer. If you or someone close to you is facing this diagnosis, ask the care team to explain why they recommend their plan and what side effects to expect, so you can go into treatment knowing what is coming.
For clinicians and researchers
Design: Cochrane systematic review and random-effects meta-analysis of RCTs in women with locally advanced cervical cancer (FIGO 2018 IB3/IIA2/IIB/IIIA-C/IVA) comparing neoadjuvant chemotherapy plus radical surgery with chemoradiotherapy; 3 RCTs, 1326 women.
Main result: Five-year overall survival: hazard ratio (HR) 1.11, 95% confidence interval (CI) 0.90 to 1.36 (2 studies, 1259 participants; low certainty), little to no difference. Grade ≥ 3 acute toxicity: risk ratio (RR) 1.82, 95% CI 1.45 to 2.29 (moderate certainty), higher with surgery.
Main limitation: Certainty of evidence was very low to moderate, downgraded for risk of bias, indirectness and imprecision; disease-free and progression-free survival rested on one study each, with older radiotherapy techniques and high cross-over.
Open question: Whether NACT plus radical surgery has any role where high-quality radiotherapy is unavailable remains untested; the evidence is insufficient, and late toxicity and recurrence outcomes need better trials.
Cite this article
Mongevity Desk. Women’s cancers: chemo then surgery does not beat chemoradiation for cervical cancer. Mongevity. Published November 21, 2026. Accessed November 22, 2026. https://mongevity.science/cancer/2026/11/cervical-cancer-chemo-surgery-vs-chemoradiation/Mongevity Desk. Women’s cancers: chemo then surgery does not beat chemoradiation for cervical cancer [Internet]. Mongevity; 2026 Nov 21 cited 2026 Nov 22]. Available from: https://mongevity.science/cancer/2026/11/cervical-cancer-chemo-surgery-vs-chemoradiation/Mongevity Desk. (2026, November 21). Women’s cancers: chemo then surgery does not beat chemoradiation for cervical cancer. Mongevity. https://mongevity.science/cancer/2026/11/cervical-cancer-chemo-surgery-vs-chemoradiation/
<a href="https://mongevity.science/cancer/2026/11/cervical-cancer-chemo-surgery-vs-chemoradiation/">Women’s cancers: chemo then surgery does not beat chemoradiation for cervical cancer</a>
Free to share or quote with credit and a link.
Questions and answers
- Is chemo followed by surgery better than chemoradiation for cervical cancer?
- Not according to this review. Five-year survival looked about the same, but severe short-term side effects were probably more common with chemo plus surgery.
- Does this change the standard treatment for advanced cervical cancer?
- No. Chemoradiation remains the standard of care where high-quality radiation is available.
- Why was chemo plus surgery proposed as an alternative?
- Chemoradiation can be hard on the body, and radiation equipment is limited or unavailable in some places in the world.
- How big was the evidence behind this review?
- It combined 3 randomized trials with 1,326 women in total. For several results only one trial had data, so those results are very uncertain.





